| P/E (FY) | 20.4 | Sales (TTM) | $37.5M |
| Earnings (TTM) | $10.8M | ROE | 9.54% |
| Net Margin | 29.30% | ROIC | 26.84% |
| Debt / Equity | 0.00 | TD / EBITDA | — |
| EPS Growth 3Y | −8.35% | Sales Growth 3Y | −9.68% |
Utah Medical Products offers medical devices for the healthcare industry in the United States, Europe, and internationally. Its products include fetal monitoring accessories, vacuum-assisted delivery systems, DISPOSA-HOOD infant respiratory hoods, and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO neonatal devices such as umbilical catheters and dialysis sets, and the LETZ system for excising cervical and lower genital tract lesions.
| Market Cap | $225.9M | Trading Days | 5292 |
| 52W High | 75.75 |
| 52W Low | 53.66 |
| % Off High | −6.32% |
| YTD | 28.01% | 1Y | 25.28% |
| 3Y | −21.76% | 5Y | −11.93% |
| 10Y | 26.98% | Since incept. (ann.) | 8.17% |
Global 71% · Ous 29%
| Ann. Volatility (1Y) | 29.20% | Ann. Volatility (3Y) | 24.12% |
| Sharpe (1Y) | 0.93 | Sharpe (3Y) | −0.20 |
| Max Drawdown (1Y) | −15.77% | Max Drawdown (3Y) | −45.74% |
| Beta (3Y, vs SPY) | 0.71 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| OBIO | Orchestra BioMed Holdings, Inc. | $231.1M | — |
| EMBC | Embecta Corp. | $213.0M | 2.2 |
| ANIK | Anika Therapeutics, Inc. | $201.6M | — |
| INFU | InfuSystem Holdings, Inc | $200.2M | 32.0 |
| PROF | Profound Medical Corp. | $263.4M | 5.1 |
| TMCI | TREACE MEDICAL CONCEPTS, INC. | $264.7M | — |
| TLSI | TriSalus Life Sciences, Inc. | $265.9M | — |
| LUCD | Lucid Diagnostics Inc. | $185.7M | — |
| OSUR | ORASURE TECHNOLOGIES INC | $276.8M | — |
| KRMD | KORU Medical Systems, Inc. | $184.2M | — |
| PDEX | PRO DEX INC | $179.9M | 21.1 |
| SGHT | Sight Sciences, Inc. | $288.4M | — |
